Both in Pharmaceuticals
Oric Pharmaceuticals vs Omeros
Over the past year ORIC returned +15.1% and OMER returned +360.5%; their daily moves had a correlation of 0.05.
ORIC +15.1% OMER +360.5%Growth of $1, one year, split-adjusted
| Metric | ORIC | OMER |
|---|---|---|
| Price | $13.37 | $19.25 |
| Market cap | $1.39B | $1.39B |
| Today | +0.75% | −0.93% |
| 1 month | +1.0% | +3.4% |
| 6 months | +9.7% | +96.2% |
| Year to date | +63.4% | +12.1% |
| 1 year | +20.2% | +331.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 97.2% |
| Net margin | — | 46.4% |
| P/E (TTM) | — | 11.2× |
| Price / sales | — | 36.3× |
| Net cash | $264.8M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | 69.4% | 79.0% |
| Short % of float | 27.3% | 19.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).